Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Teva Pharmaceutical Industries Ltd (ADR) Company Profile (NASDAQ:TEVA)

Consensus Ratings for Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) (?)
Ratings Breakdown: 7 Hold Rating(s), 12 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: $59.16 (11.65% upside)

Current Analysts' Coverage Summary for Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/4/2014ISI GroupInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
8/5/2014Maxim GroupInitiated CoverageBuy$62.00ViewTweet This Rating  Share This Rating on StockTwits
8/4/2014ZacksReiterated RatingNeutral -> Neutral$57.00ViewTweet This Rating  Share This Rating on StockTwits
8/1/2014Canaccord GenuityBoost Price TargetHold$55.70 -> $58.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2014BMO Capital MarketsBoost Price Target$57.00 -> $59.00ViewTweet This Rating  Share This Rating on StockTwits
7/30/2014Sterne AgeeBoost Price Target$53.00 -> $56.00ViewTweet This Rating  Share This Rating on StockTwits
7/28/2014JPMorgan Chase & Co.Reiterated RatingNeutral$56.00 -> $58.00ViewTweet This Rating  Share This Rating on StockTwits
7/24/2014BarclaysBoost Price TargetOverweight$65.00 -> $70.00ViewTweet This Rating  Share This Rating on StockTwits
7/22/2014Deutsche BankInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
6/10/2014Wells Fargo & Co.Initiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
6/6/2014ArgusUpgradeHold -> Buy$58.00ViewTweet This Rating  Share This Rating on StockTwits
5/16/2014Jefferies GroupReiterated RatingBuy$61.00ViewTweet This Rating  Share This Rating on StockTwits
5/2/2014RBC CapitalBoost Price Target$52.00 -> $57.00ViewTweet This Rating  Share This Rating on StockTwits
4/7/2014National Alliance SecuritiesInitiated CoverageBuy$64.22ViewTweet This Rating  Share This Rating on StockTwits
4/4/2014Buckingham ResearchBoost Price Target$42.00 -> $58.00ViewTweet This Rating  Share This Rating on StockTwits
4/2/2014Standpoint ResearchBoost Price TargetBuy$55.00 -> $66.00ViewTweet This Rating  Share This Rating on StockTwits
4/1/2014Sanford C. BernsteinBoost Price Target$50.00 -> $60.00ViewTweet This Rating  Share This Rating on StockTwits
4/1/2014CRT CapitalBoost Price TargetBuy$55.00 -> $60.00ViewTweet This Rating  Share This Rating on StockTwits
3/28/2014Citigroup Inc.Boost Price TargetFocus List$56.00 -> $60.00ViewTweet This Rating  Share This Rating on StockTwits
3/18/2014Goldman SachsUpgradeSell -> Neutral$40.00 -> $52.00ViewTweet This Rating  Share This Rating on StockTwits
3/14/2014Morgan StanleyUpgradeUnderweight -> Equal Weight$52.00ViewTweet This Rating  Share This Rating on StockTwits
3/6/2014Leerink SwannUpgradeMarket Perform -> Outperform$65.00ViewTweet This Rating  Share This Rating on StockTwits
1/29/2014TheStreetUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
11/20/2013SusquehannaUpgradeNeutral -> Positive$43.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
10/14/2013OppenheimerInitiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
9/13/2013Morgan JosephLower Price TargetOverweight -> Neutral$45.00 -> $43.00ViewTweet This Rating  Share This Rating on StockTwits
12/3/2012Credit SuisseLower Price TargetOutperform$51.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
12/3/2012Cowen and CompanyReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/1/2012 forward)
Discuss Teva Pharmaceutical Industries Ltd (ADR)